The sex-dependent expression and growth hormone (GH) regulation of rat liver glutathione S-transferase (GST) was examined using oligonucleotide probes that distinguish between closely related class Alpha (Ya1, Ya2, Yc) and class Mu (Yb1, Yb2, Yb3) GST mRNAs [Waxman, Sundseth, Srivastava and Lapenson (1992) Cancer Res. 52, 5797-5802]. Northern-blot analysis revealed that the steady-state levels of GST Ya1, Yb1 and Yb2 mRNAs are 2.5-3-fold higher in male as compared with female rat liver. In contrast, GST Yc and Ya2 mRNAs were expressed at a 2-3-fold higher level in female rat liver. Microsomal GST mRNA did not exhibit significant sex-dependent differences in rat liver. Treatment of male rats with GH by continuous infusion suppressed expression of the male-dominant GST Ya1, Yb1 and Yb2 mRNAs to levels at or below those found in female rat liver. This suppressive effect of GH was liver-specific, insofar as GH treatment did not alter kidney GST Yal mRNA levels. Hypophysectomy increased expression of the male-dominant GSTs,
INTRODUCTION
Glutathione S-transferase enzymes (GSTs) catalyse the conjugation of glutathione to structurally diverse endogenous and xenobiotic substrates, including many environmental carcinogens and other electrophilic chemicals [1, 2] . Cytosolic GSTs are comprised of two subunits which homo-and hetero-dimerize by non-covalent interactions and can be classified into at least four distinct gene families (designated Alpha, Mu, Pi and Theta) on the basis of their primary structures [3] [4] [5] . Individual rat GSTs are designated according to the Y subunit nomenclature, as tabulated in [2] . Corresponding numeric subunit designations are Ya, GST subunit 1; Yc, subunit 2; Yb1, subunit 3; and Yb2, subunit 4 . A structurally distinct microsomal GST (msGST) that catalyses many of the same conjugation reactions has also been described [6] .
GSTs can metabolize, and thereby inactivate, several alkylating agent chemotherapeutic drugs, including melphalan, chlorambucil and 1,3-bis(2-chloroethyl)-l-nitrosourea [7] [8] [9] . Overexpression of individual GSTs in tumour cells can consequently confer anti-cancer drug resistance, which may be reversed, at least in part, by the application of suitable GST inhibitors [10, 11] (for reviews, see [12, 13] ). While drug selection pressure is undoubtedly an important factor in development of the stable GST overexpression that characterizes these tumour cells, other factors can lead to reversible changes in GST enzyme levels. These include (a) enzyme induction in response to various drugs and chemicals, and (b) changes in enzyme levels in response to endogenous hormonal factors. While much is known about the responsiveness of individual GSTs to general inducers of drug particularly in female rats (e.g. 8 -fold elevation of GST Ya1 mRNA). GST Yc mRNA was increased approx. 2-fold in hypophysectomized males, indicating that this mRNA is subject to negative regulation by one metabolism, such as phenobarbital, f6-naphthoflavone, butylated hydroxyanisole and dexamethasone [14] [15] [16] , much less is known about the endogenous hormonal factors that regulate GST expression.
Several cytosolic GST activities [17, 18] , individual GST subunit levels [19, 20] and those of their mRNAs [21] vary through post-natal liver development. Sexual dimorphism in the expression of some liver and kidney GSTs has been suggested on the basis ofimmunochemical studies, but in most cases differences in the expressed levels of individual subunits have been reported to be small (typically approx. 2-fold) [22] [23] [24] [25] . A regulatory role for pituitary-dependent factors is suggested by the increase in some liver cytosolic GST activities and proteins in hypophysectomized rats [26] . Whereas the pituitary polypeptide hormone adrenocorticotrophic hormone is a major regulator of adrenal GST activity [26] , the pituitary factors involved in the regulation of liver GSTs have not been well defined. With the recent development of methods to monitor the expression of GST mRNAs using gene-specific oligonucleotide probes [16] , it is now possible to characterize the responses ofindividual GST mRNAs to hormonal factors.
Previous studies from this laboratory have shown that the anti-cancer drug cisplatin can have long-term effects on the expression in liver of two specific Alpha-class GSTs and their mRNAs [16] . Thus GST Ya1 is selectively suppressed and GST Yc is induced in rat liver following cisplatin treatment. Cisplatin has also been shown to feminize the profile of cytochrome P-450 and other rat liver microsomal enzymes involved in steroid hormone and drug metabolism [27] . In the case of the cytochrome P-450s, cisplatin's effects on liver enzyme expression are restricted Abbreviations used: GST, glutathione S-transferase; msGST, microsomal GST; GH, growth hormone.
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to the sex-dependent cytochrome P-450s and their mRNAs [28] , and are a consequence of the gonadal toxicity and the loss of circulating testosterone that is caused by cisplatin treatment [27] . The specific effect of cisplatin and GST Ya1 and GST Yc mRNA and protein levels [16] therefore suggest that these two GSTs may also be subject to hormonal regulation and sex-dependent expression in rat liver. In the present study, we have used a panel ofrat GST-gene-specific oligonucleotide probes [16] [29] . In the experiment shown in Figure 2 (see below), human GH was given to hypophysectomized female rats twice daily for 7 days by subcutaneous injection (50 ,tg of GH/injection). This treatment was verified to stimulate the expression of the male-specific liver cytochrome P-450 2C1 1 [30] .
Intact adult male rats were treated for 7 days with human GH (specific activity 2.4 i.u./mg) or rat GH (specific activity 1.8 i.u./ mg) (National Hormone and Pituitary Programme) delivered as a continuous infusion using Alzet osmotic minipumps implanted under ketamine anaesthesia [31] . GH treatments were at 20-25 ng of hormone/g of body weight per h, a dose shown to provide a continuous level of circulating rat GH (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) ng/ml, corresponding to the physiological range for intact female rats) when administered to hypophysectomized male rats [30] . Killing of rats at the age of [11] [12] [13] weeks (i.e. 3-4 weeks after hypophysectomy), and isolation and storage of liver and kidney tissue was carried out as described [27] . All analytical results are expressed as means+ S.D. for n = 3 or 4 individual rats/ treatment group.
Oligonucleotide probes and Northern-blotting analysis Oligonucleotide synthesis, purification and 32P end-labelling were performed as described previously [16, 32] . Oligonucleotides used in the present study were as follows: GST Yal (ON-24), Ya2 (ON-43), Yc (ON-47), Ybl (ON-44), Yb2 (ON-45) and msGST (ON-37) [16] . The rat at-tubulin oligonucleotide probe ON-50 [33] was employed as a control, to verify RNA load consistency and RNA integrity. a-Tubulin mRNA was found to be unaffected electrophoresis through formaldehyde-containing agarose gels (10-15 jug of RNA/lane) and Northern transfer to nylon filters followed by u.v. cross-linking were carried out as described elsewhere [32] . The nylon filters were probed with oligonucleotides complementary to individual GST mRNAs with the hybridization temperature (40°C or 45 'C) and the percentage of formamide (0-20 %) adjusted empirically for each oligonucleotide, taking into account its length and percentage G + C content [16] . Nylon filters were washed at the hybridization temperature and then air dried and exposed to Kodak XAR-5 film with two intensifying screens at -80°C for 2-6 days. Northern blots were stripped and then reprobed sequentially with additional oligonucleotide probes.
RNA quantitation by slot blotting was carried out as described previously [32] . Briefly 0.67, 2 and 6 ,ug of each RNA sample was applied to individual wells of a Minifold II slot-blot apparatus mounted with a nylon filter. Filters were then u.v. cross-linked, prehybridized, hybridized with individual GST oligonucleotides and then washed using the same conditions employed for Northern blotting. Relative mRNA contents for each experimental group were determined by scanning laser densitometry of autoradiographs of the slot blots and are presented as averages of results for each individual liver RNA sample based on two or three different loadings of the slot blot.
RESULTS

Sex-dependent expression of GST mRNAs in rat liver
Since cisplatin and some of its analogues can modulate the expression of GSTs Ya1 and Yc and their mRNAs in rat liver [16] in a manner that is similar to the effects that this drug has on several sex-dependent rat liver cytochrome P-450s [28] , we examined whether these two GST mRNAs are also subject to hormone regulation and sex-dependent expression. Total liver RNA was isolated from male and female rats and analysed on Northern blots probed with oligonucleotides specific for GSTs Ya1 and Yc, as well as for several other liver-expressed GST mRNAs. Figure 1 demonstrates that the mRNAs encoding GSTs Yal, Yb1 and Yb2 are expressed in adult male rats at levels that are several-fold higher than those found in adult female rats. In contrast, GST Yc and GST Ya2 mRNAs are both expressed in females at a higher level than in males (Figure 1) . No major sexdependent differences were observed in the expression of msGST mRNA (see Figure 2e) . Slot-blot analysis confirmed these findings and revealed that GST Yal, Yb1 and Yb2 mRNAs are approx. 2.5-3-fold more abundant in males than in females, while the female-dominant GST Yc mRNA is 2-3-fold higher in females ( Table 1) .
The pituitary polypeptide hormone GH is known to play a major role in the regulation of several sex-dependent liver enzymes, of which the cytochrome P-450s are a well-studied example [34] . Male-specific liver cytochrome P-450s are positively regulated by the intermittent (pulsatile) pattern of circulating GH that is present in adult male rats, while several femalespecific and female-dominant liver cytochrome P-450s are positively regulated by the continuous plasma GH pattern associated with adult females. In order to evaluate whether GH also influences the expression of the sex-dependent liver GSTs, adult male rats were treated with human or rat GH by continuous infusion using an osmotic minipump. This treatment overrides the natural endogenous GH pulse found in male rats, and imparts a continuous profile of circulating GH that closely resembles the one found in females [30] . Northern-blot analysis revealed that this treatment leads to significant decreases in the levels of each of the male-dominant liver GST mRNAs, i.e. Yal, by the treatments employed in this study.
Isolation of total RNA from frozen liver and kidney tissue, Yb1 and Yb2, and essentially abolishes the differences in their expression between the sexes (Figure 1 ). This suppressive effect of GH, observed with both human GH and rat GH, is analogous to that described for several male-specific liver cytochrome P-450 mRNAs (2C1 1, 3A2 and 4A2), excepting that the suppression is more complete in the case of the cytochrome P-450s [35] . GH had no significant effect on msGST mRNA levels, in accord with the sex-independence of its expression (results not shown).
Several female-dominant and female-specific cytochrome P-450 enzymes are positively regulated by continuous GH exposure and their expression in male rats can be increased substantially by continuous GH treatment [34] . Although GST Yc is female dominant in rat liver (see above), continuous GH treatment of male rats had only a small effect in the case of animals treated with rat GH and had no effect when using human GH [cf. Figure  1 (e) taking into account tubulin control in Figure 1 (f]. Con- Shown is a Northern blot of rat liver RNA samples probed for the indicated GST mRNAs as described in Figure 1 . Abbreviation: Ms, msGST mRNA. Liver RNA samples were prepared from individual normal female rats (F; lanes 1, 2, 9 and 10), male rats (M; lanes 7 and 8), hypophysectomized female rats (Hx; lanes 3 and 4), or hypophysectomized females treated with human GH given twice daily by subcutaneous injection for 7 days (Hx/GHi; lanes 5 and 6).
Migration of the 18S ribosomal RNA is marked by a horizontal line at the left-hand side of each panel. that more substantial increases in these female-dominant GST mRNAs would be achieved at higher doses of GH.
Effect of hypophysectomy and GH replacement
Some male-specific liver cytochrome P-450s (e.g. cytochrome P-450 2C 1) are positively regulated by the intermittent plasma GH pulses that are a characteristic of adult male rats, whereas others (e.g. cytochrome P-450s 3A2 and 2A2) are not obligatorily dependent on GH pulsation, but rather, are negatively regulated by the profile of pituitary-dependent hormones found in adult female rats [34, 36] . These two classes of male-specific, GHregulated liver enzymes are readily distinguished by their responses to hypophysectomy, which markedly decreases expression of enzymes of the former group, but substantially elevates (de-represses) expression of the latter group of enzymes, particularly in adult female rats. We therefore examined the effects of hypophysectomy and hormone replacement on the expression of the sex-dependent liver GSTs (Figure 2 ). Northern blotting and slot-blot analysis revealed that hypophysectomy elevated GST Ya1 mRNA to similar levels in adult male and female rats, corresponding to an approx. 3-fold increase in hypophysectomized adult male rats and an approx. 8-fold increase in adult females (Figure 3a ; see also To test this hypothesis we treated hypophysectomized rats with GH and thyroxine, the two pituitary-dependent factors that play a significant role in the expression of the male-specific liver cytochrome P-450s [29, 37] . Continuous GH treatment led to a 7075 % decrease in GST Yal mRNA levels in both male and female hypophysectomized rats (Figure 3a) . Thyroxine also decreased levels of Yal, although less extensively than did GH, while thyroxine in combination with GH was more effective than either hormone alone at decreasing GST Yal expression from the high levels found in hypophysectomized rats to the substantially lower levels present in untreated female controls. GST Ybl and GST Yb2 mRNA levels were also decreased by continuous GH treatment of hypophysectomized rats (Figure 4) . By contrast, treatment with GH by intermittent injection, a protocol designed to mimic the pulsatile pattern of plasma GH present in adult male rats [38, 39] , had no effect on the elevated levels of Ya1, Yb1 or Yb2mRNA present in hypophysectomized female rats ( Figure  2 , lanes 5 and 6 compared with lanes 3 and 4). As in the case of GST Yal, thyroxine in combination with continuous GH further decreased these mRNAs to levels that were at or below intact female controls.
Hypophysectomy led to a 2-fold increase in GST Yc mRNA levels in male rats, but had only a small positive effect on the already high mRNA levels found in females (Figure 3b ). Treatment with GH by continuous infusion had little effect, while thyroxine increased the level of GST Yc mRNA in the hypophysectomized rats by 1.5-2-fold. Thyroxine also increased the levels of GST Yb1 mRNA (but not the other male-dominant GST mRNAs) in hypophysectomized female rats (Figure 4a ). The fact that GST Yc expression in adult female rats is not decreased by hypophysectomy (Figure 3b Relative mRNA levels were determined by slot-blotting analysis of the same series of RNA samples analysed in Figure 3 .
hormones that characterizes other female-dominant liver enzymes and mRNAs, such as steroid 5a-reductase and cytochrome P-450 2C7 [33] . While the high-level expression of GST Yc mRNA in hypophysectomized rats is analogous to that of the female-dominant liver cytochrome P-450 2A1, that enzyme, unlike GST Yc, is negatively regulated by thyroxine [40] .
Expression of GST in kidney GST Ya1 and Yc mRNAs are expressed in rat kidney at levels that are at least as high as in liver. Expression of both these mRNAs occurs at a somewhat higher level in male as compared with female rat kidney [16] . Treatment of intact male rats with GH, by continuous exposure, did not have any detectable effect, however, on the expression in kidney of either GST Yal or Yc mRNA (results not shown). Thus, the suppressive effects of continuous GH on liver GST Yal mRNA levels ( Figure 1 ) are not achieved in kidney.
DISCUSSION
Hormonal regulation has been reported for several classes of liver drug-metabolizing enzymes, including multiple cytochrome P-450s [34, 41] , sulphotransferases [42] and N-acetyltransferase [43] . [45, 46] . In addition to these effects of GH, we observed an important role for thyroid hormone in the regulation of GST mRNA expression, with thyroxine suppressing the level of GST Yal mRNA and elevating the level of GST Yc mRNA in hypophysectomized rats. By contrast, thyroxine had no effect on Yb2 mRNA levels, while its effects on Yb1 differed between males and females. These effects of thyroxine on GST Ya1 and Yc (Alpha class) mRNAs are analogous to the feminizing effects that thyroid hormone can have on liver cytochrome P-450 expression [33, 37] . Since also be occurring, as indicated by our finding that thyroxine enhanced the GH suppression of GST Yb2 mRNA levels in hypophysectomized rats, even though thyroxine alone had no effect on this mRNA. The requirement of thyroid hormone to maintain normal hepatic GH receptor levels [47] could provide an explanation for this result.
Our conclusions in this study are largely consistent with those of Staffas et al. in a report that appeared after completion of this present study [48] . Those [48] reflect the summation of the two closely migrating subunits 1 peaks, which respectively correspond to GSTs Yal and Ya2 [49] . In addition, GST subunit 2 protein (GST Yc) was found in [48] to be relatively unaffected by the hormonal factors examined, in contrast with the present characterization of GST Yc mRNA as female dominant. It is conceivable that this could reflect a differential regulation of this GST protein as compared with its mRNA. However, the earlier report that GST Yc protein levels are higher in female than in male rat liver [23] , and our observation that the anti-cancer drug cisplatin induces both GST Yc mRNA and protein by processes that probably involve alterations in endogenous hormonal regulators of these GSTs [16] , suggest that this may not be the case.
We previously reported [16] that treatment of adult male rats with the anti-cancer drug cisplatin results in the suppression of GST Yal and the elevation of GST Yc mRNA and protein in liver in a manner that is similar to the effects that cisplatin has on several hormone-regulated liver cytochrome P-450s [27, 28] . The present demonstration that GST Ya1 and Yc mRNAs are indeed expressed in a sexually dimorphic fashion, in turn, suggests that these effects of cisplatin derive from its depletion of circulating testosterone [27, 50, 51] , which is expected to have a substantial impact on the plasma GH profiles of affected rats [52] . In view of the important role that GSTs play in metabolism, leading to inactivation of a number of therapeutically useful alkylatingagent anti-cancer drugs [12] , the effects of cisplatin on these sexdependent GST mRNAs could lead to clinically significant drug interactions in the case of chemotherapeutic regimens involving cisplatin in combination with other alkylating agents. Further study will be required to establish whether human liver GSTs, which undergo distinct developmental changes in liver and other tissues [53] , are also subject to sex-d'ependent expression and hormone regulation. If this is found to be the case, it will be of interest to determine whether cisplatin or other anti-cancer drugs alter the normal patterns of GST enzyme expression in cancer patients in a manner that impacts on anti-cancer drug activity or host toxicity. Gender-related differences in the expression of class Alpha, Mu and Pi GSTs in human colon tissue have recently been reported [54] , but the underlying hormone regulatory mechanisms, and the possible importance of this gender dependence for processes such as carcinogen susceptibility and drug sensitivity, have yet to be established.
